Authera

Press release! We are thrilled to share that we have received funding from The Norwegian Association of the Blind and Partially Sighted to advance our antibody-based candidate for severe eye diseases. This support propels our mission to develop innovative treatments addressing critical unmet needs in ophthalmology, offering hope to those with profound vision impairments. Thank you for believing in our vision! Learn more at www.authera.bio Norges Blindeforbund ShareLab The Life Science Cluster Norges forskningsråd Forskningsparken - Oslo Science Park MedWatch Norge

This week we had the pleasure of participating in the Belgium & Norway Life Sciences Days, part of the Belgium Economic Mission to Norway! 🇧🇪🇳🇴 Our CEO Simone Mester, contributed to a panel on "Universities’ role in innovation ecosystems," discussing how universities can foster entrepreneurial culture for students and young academics. She also presented at the Precision Immunotherapy Alliance, PRIMA seminar "From groundbreaking research to innovation in academia and industry," sharing insights on transitioning from academia to establishing a biotech company. It all concluded with an Official Reception attended by Her Royal Highness Princess Astrid of Belgium. We appreciate the exchange of experiences and look forward to future cross-border collaborations! Dominique Blanquet Fredrik Arneberg David Humphreys Jan Terje Andersen Esben A. Nilssen Belgian Foreign Trade Agency (BFTA) ShareLab The Life Science Cluster Inven2 Veksthuset for verdiskaping – UiO Growth House University of Oslo Norwegian Society for Immunology (NSI)Oslo Science City Forskningsparken - Oslo Science Park Innovation Norway

We welcome you to a seminar to exemplify and discuss why groundbreaking basic research is a prerequiste for development of biomedical technologies and new tailored medicines, in academia and industry as well as in partnership🔬 Keynote speaker David Humphreys Executive Director, Head of #Antibody and Novel Therapeutics. UCB Pharma, UK. Organized by Precision Immunotherapy Alliance, PRIMA together with Norwegian Society for Immunology (NSI) and Veksthuset for verdiskaping – UiO Growth House. Time and place: June 18, 2024 10:00 AM – 12:00 PM, Forskningsparken - Oslo Science Park, Meeting room Fauna - Flora Lounge. ShareLab Authera Sander J. Tufte Jens Halvard Grønlien Inven2 The Life Science Cluster Oslo Cancer Cluster Oslo Science City Norges forskningsråd Innovasjon Norge Nærings- og fiskeridepartementet Simone Mester Legemiddelindustrien (LMI) The Antibody Society Hilde Nebb

This week, our CEO Simone Mester had the pleasure of joining The Jackson Laboratory at their EU Workshop, "Predicting the Response to Immunotherapies Using Humanized Models," in Amsterdam and Basel. Simone shared insights about our FcRn-focused platform and enjoyed engaging discussions on this important topic. A big thank you to the organizers for hosting a fantastic event and for the invitation to present - Adriano Flora, Ralph Gareus, Una Kilberg CMP, CEM, CAPM, Phil Gaskin, Nijaguna Bethur. The Life Science Cluster ShareLab The Antibody Society Innovation Norway Norges forskningsråd

Last chance to register for the upcoming JAX workshop in Europe where innovation converges with expertise in translational in vivo pharmacology.👇

We're thrilled to announce the well-deserved promotion of Gaia Calamera to Senior Scientist! 🚀 We are proud to have have Gaia as part of team and excited to see her embark on this new chapter of her career.

We are excited to share that our CEO Simone Mester is an invited speaker at the upcoming The Jackson Laboratory-hosted EU workshop - "Predicting the Response to Immunotherapies Using Humanized Models". On the 21st of May in Amsterdam and 23rd of May in Basel, Simone will give a talk on FcRn biology and its implications from a therapeutic perspective. We hope to see you there! Register here: https://lnkd.in/eRJDcdNg Ralph Gareus Adriano Flora Nijaguna Bethur The Life Science Cluster ShareLab Innovation Norway Norges forskningsråd The Antibody Society

We are looking forward to the 4th Fc-Mediated Function Summit in Boston 16-18th of April! Our co-founder and Chairman Jan Terje Andersen will be there as invited expert speaker and will talk about Biology-Guided Engineering of Antibody & Albumin Molecules. Reach out if you would like to talk science or discuss opportunities! Hanson Wade Group The Life Science Cluster ShareLab Norges forskningsråd Innovation Norway The Antibody Society

Last week we had a great time attending Biologics by Oxford Global in London! Simone Mester had the pleasure of presenting ongoing activities in Authera at the Biologics Innovation and Collaboration track. Thank you to the organizers for the invitation to present and for great talks and discussions! The Life Science Cluster Norges forskningsråd Innovation Norway ShareLab Oxford Global

We are looking forward to attending Biologics 2024 13th-15th of March in London! Our CEO Simone Mester will give a glimpse into our platform and antibody development during the Biologics innovation and Collaboration track on the first day of the conference. Oxford Global The Life Science Cluster ShareLab